Table 3 Correlation between miR-196b expression and clinicopathological characteristics of 72 HCC Patients
Clinicopathological feature | miR-196b expression | P value | |
|---|---|---|---|
High n (%) | Down n (%) | ||
Age | >0.05 | ||
<55 years | 21 (52.5) | 19 (47.5) | |
≥55 years | 18 (56.2) | 14 (43.8) | |
Gender | >0.05 | ||
Female | 16 (57.1) | 12(42.9) | |
Male | 23 (52.3) | 21 (47.7) | |
Tumor size | <0.05 | ||
>5 cm | 33 (67.3) | 16 (32.7) | |
≤5 cm | 6 (26.1) | 17 (73.9) | |
AFP (μg/L) | >0.05 | ||
Normal | 17 (50) | 17 (50) | |
Abnormal | 22 (57.9) | 16 (42.1) | |
HBsAg | >0.05 | ||
Present | 29 (55.8) | 23 (44.2) | |
Absent | 10 (50) | 10 (50) | |
Lymph node metastasis | <0.05 | ||
Yes | 13 (65) | 7 (35) | |
No | 26 (50) | 26 (50) | |
TNM stage | <0.05 | ||
I–II | 10 (35.7) | 18 (44.3) | |
III–IV | 29 (65.9) | 15 (34.1) | |
ALBI grade | <0.05 | ||
1 | 12 (42.9) | 16 (57.1) | |
2 | 25 (59.5) | 17 (40.5) | |
3 | 2 (100) | 0 (0) | |
